Wai Yuen Tong Medicine Holdings (HKSE:00897) GF Score: 38/100 (As of Aug. 23, 2026) — 16% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:00897 Wai Yuen Tong Medicine Holdings Ltd HKSE:00897
38 GF Score
Price HK$0.29
GF Value HK$0.29
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Wai Yuen Tong Medicine Holdings GF Score?

Wai Yuen Tong Medicine Holdings HKSE:00897 38 GF Score is 38 as of Aug. 23, 2026, which is 16% below its 10-year median of 45.00. GuruFocus rates HKSE:00897 with a GF Score™ of 38/100 and a GF Value™ of HK$0.29 (Fairly Valued). The stock has 2 warning signs investors should review.

Wai Yuen Tong Medicine Holdings has the GF Score of 38, which implies that the company might have Worst future performance potential, or not enough data.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 4/10
2. Profitability Rank : 4/10
3. Growth Rank : 1/10
4. GF Value Rank : 0/10
5. Momentum Rank : 8/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Wai Yuen Tong Medicine Holdings might have Worst future performance potential, or not enough data.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Wai Yuen Tong Medicine Holdings  (HKSE:00897) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Wai Yuen Tong Medicine Holdings GF Score Related Terms

HKSE:00897 vs ZTS: GF Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Wai Yuen Tong Medicine Holdings's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Wai Yuen Tong Medicine Holdings GF Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Wai Yuen Tong Medicine Holdings's GF Score distribution charts can be found below:

* The bar in red indicates where Wai Yuen Tong Medicine Holdings's GF Score falls into.


HKSE:00897
38GF Score
Wai Yuen Tong Medicine Holdings Ltd HKSE:00897
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 38 mean?
Wai Yuen Tong Medicine Holdings (HKSE:00897) has a GF Score of 38 as of Aug. 23, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Wai Yuen Tong Medicine Holdings and its competitors. This is 16% below median its historical median of 45.00. Over the past decade, Wai Yuen Tong Medicine Holdings' GF Score has ranged from 26.00 to 56.00.
Is Wai Yuen Tong Medicine Holdings' GF Score too high?
Wai Yuen Tong Medicine Holdings' current GF Score of 38 is 16% below median its 10-year median of 45.00. Over the past 10 years, this metric has ranged from a low of 26.00 to a high of 56.00. Overall, Wai Yuen Tong Medicine Holdings has a GF Score™ of 38/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Wai Yuen Tong Medicine Holdings' GF Score compare to ZTS?
Wai Yuen Tong Medicine Holdings' GF Score of 38 can be compared against companies in the Drug Manufacturers industry. Historically, Wai Yuen Tong Medicine Holdings' own GF Score has ranged from 26.00 to 56.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Drug Manufacturers company?
A good GF Score depends on the Drug Manufacturers industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Wai Yuen Tong Medicine Holdings and its competitors. Wai Yuen Tong Medicine Holdings's current GF Score is 38, which is 16% below median its own 10-year median of 45.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wai Yuen Tong Medicine Holdings stock overvalued right now?
Based on GuruFocus' analysis, Wai Yuen Tong Medicine Holdings (HKSE:00897) is currently considered Fairly Valued. The stock's GF Value™ is HK$0.29, compared to a current price of HK$0.29 — trading right at its estimated fair value. The current GF Score is 38, which is 16% below median its 10-year median of 45.00. Wai Yuen Tong Medicine Holdings' overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Wai Yuen Tong Medicine Holdings (HKSE:00897), the current GF Score is 38 as of Aug. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Wai Yuen Tong Medicine Holdings (HKSE:00897) Overvalued in 2026?

Based on GuruFocus' analysis, Wai Yuen Tong Medicine Holdings stock appears to be undervalued. The current stock price of HK$0.29 is trading 0% below its estimated GF Value™ of HK$0.29. GuruFocus considers Wai Yuen Tong Medicine Holdings to be Fairly Valued.

Key valuation signals for HKSE:00897:

  • GF Score: 38 (16% below median its 10-year median of 45.00)
  • GF Value™: HK$0.29 vs. price of HK$0.29 (0% below fair value)
  • GF Score™: 38/100 with 2 warning signs

No single metric tells the full story. See the HKSE:00897 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Wai Yuen Tong Medicine Holdings Business Description

Address 39 Wang Kwong Road, Suite 3101, 31st Floor, Skyline Tower, Kowloon Bay, Kowloon, Hong Kong, HKG
Wai Yuen Tong Medicine Holdings Ltd is an investment holding company. The company's operating segment includes production and sale of Chinese pharmaceutical and health food products; production and sale of Western pharmaceutical and health food products and property investment and management and sale of properties. It generates maximum revenue from the production and sale of Chinese pharmaceutical and health food products which include manufacturing, processing, and sale of traditional Chinese medicine which includes Chinese medicinal products sold under the brand name Wai Yuen Tong. Geographically, it derives a majority of revenue from Mainland China.
38GF Score

Get the complete analysis for HKSE:00897

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.29
Price
HK$0.29
GF Value